Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amitava Mitra

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The AAPS Journal|February 13, 2019
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary ReportTycho Heimbach, Sandra Suarez-Sharp, Maziar Kakhi, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 19, 2022
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary reportFang Wu, Youssef Mousa, Kimberly Raines, et al.
The AAPS Journal|June 12, 2012
Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalenceJames E Polli, Jack A Cook, Barbara M Davit, et al.
Journal of Pharmaceutical Sciences|September 21, 2020
In Vitro Biopredictive Methods: A Workshop Summary ReportXavier J H Pepin, Jennifer Dressman, Neil Parrott, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary ReportNeil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, et al.
Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2021
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP reviewZahari Vinarov, Mohammad Abdallah, José A G Agundez, et al.
Journal of Pharmaceutical Sciences|November 5, 2020
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary ReportAmitava Mitra, Sandra Suarez-Sharp, Xavier J H Pepin, et al.
Molecular Pharmaceutics|December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop ReportChrister Tannergren, Sumit Arora, Andrew Babiskin, et al.
The Lancet. Oncology|October 3, 2024
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trialEunice S Wang, Ghayas C Issa, Harry P Erba, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The AAPS Journal|February 13, 2019
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary ReportTycho Heimbach, Sandra Suarez-Sharp, Maziar Kakhi, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 19, 2022
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary reportFang Wu, Youssef Mousa, Kimberly Raines, et al.
The AAPS Journal|June 12, 2012
Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalenceJames E Polli, Jack A Cook, Barbara M Davit, et al.
Journal of Pharmaceutical Sciences|September 21, 2020
In Vitro Biopredictive Methods: A Workshop Summary ReportXavier J H Pepin, Jennifer Dressman, Neil Parrott, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary ReportNeil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, et al.
Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2021
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP reviewZahari Vinarov, Mohammad Abdallah, José A G Agundez, et al.
Journal of Pharmaceutical Sciences|November 5, 2020
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary ReportAmitava Mitra, Sandra Suarez-Sharp, Xavier J H Pepin, et al.
Molecular Pharmaceutics|December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop ReportChrister Tannergren, Sumit Arora, Andrew Babiskin, et al.
The Lancet. Oncology|October 3, 2024
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trialEunice S Wang, Ghayas C Issa, Harry P Erba, et al.
Pageof 8